Fisher & Paykel Healthcare Corporation
Fisher & Paykel Healthcare is a global leader in the design, manufacturing and marketing of medical devices, with a focus on innovative products for respiratory care, acute care, surgery and obstructive sleep apnoea.
Products are manufactured in NZ and Mexico and are primarily sold to hospitals and healthcare facilities around the world through an extensive distribution network.
F&P is listed on both the NZX and ASX and is one of the largest listed companies on the NZX in terms of market capitalisation. The company employs over 5,000 people and is a leader in research and development, investing more than $100 million a year into innovation. Lewis Gradon took over as CEO in 2016.
Company Details
Registered Office:
15 Maurice Paykel Place, East Tamaki, Auckland 2013
Postal Address:
PO Box 14348, Panmure, Auckland 1741
Telephone:
+64 9 574 0100
Facsimile:
+64 9 574 0158
Website:
http://www.fphcare.co.nz/
First Listed:
01/11/1979
Balance Date:
31 March
AGM:
29/08/2023
Directors and Executives
Michael Daniell
Director
Lewis Gradon
Chief Executive Officer and Managing Director
Pip Greenwood
Independent Non-Executive Director
Scott St John
Chair
Raelene Leonard
General Counsel / Company Secretary
Lisa McIntyre
Independent Non-Executive Director
Graham McLean
Independent Non-Executive Director
Neville Mitchell
Independent Non-Executive Director
Cather Simpson
Independent Non-Executive Director
Lyndal York
Chief Financial Officer
Announcements
| Title | Date | Type |
|---|---|---|
| FPH announces 2025 Investor Event in Melbourne | Wed, Apr 30 2025 10:46 am | GENERAL |
| SPH Notice - Pinnacle Investment Management Group Limited | Mon, Apr 14 2025 04:16 pm | SHINTR |
| FPH to announce full year results on 28 May 2025 | Thu, Apr 10 2025 08:31 am | GENERAL |
| SPH Notice - Pinnacle Investment Management Group Limited | Wed, Apr 09 2025 04:55 pm | SHINTR |
| Ongoing Disclosure Notices – Employee Share Purchase Scheme | Mon, Apr 07 2025 04:10 pm | SHINTR |
| Capital Change Notices - NZ & AU ESPS | Mon, Apr 07 2025 03:53 pm | SECISSUE |
| New US tariffs announced today | Thu, Apr 03 2025 10:31 am | GENERAL |
| Capital Change Notice - North America ESPP | Thu, Apr 03 2025 09:11 am | SECISSUE |
| FPH launches F&P Nova™ Nasal mask in NZ and AU | Wed, Mar 12 2025 08:33 am | GENERAL |
| Ongoing Disclosure Notices – Employee Share Purchase Plan | Tue, Mar 11 2025 01:28 pm | SHINTR |
Major Holdings Announcements
| Date | Name | No. Held | % | Current |
|---|---|---|---|---|
| 16/10/23 | Pinnacle Investment Management Grou | 36,059,206 | 5.09 | 6.20 |
| 13/10/23 | Hyperion Asset Management Limited | 35,452,466 | 5.07 | 6.09 |
| 05/09/23 | Mitsubishi UFJ Financial Group, Inc | 48,116,648 | 7.25 | 8.27 |
| 03/08/21 | The Vanguard Group, Inc. | 21,144,194 | 5.26 | 3.67 |
| 13/07/21 | BlackRock, Inc. and related bodies | 37,908,016 | 5.01 | 6.58 |
| 17/08/20 | The Capital Group Companies, Inc. | 27,621,429 | 5.36 | 4.80 |
| 04/12/17 | Bennelong Funds Management Group Pt | 28,250,795 | 5.00 | 4.95 |
| 22/06/17 | Northcape Capital Pty Limited | 28,174,622 | 5.01 | 4.96 |
Director’s Interests Announcements
| Date | Name | No. Held | % | Details | Other |
|---|---|---|---|---|---|
| 20/12/23 | Scott A. St John | 22,569 | - | - | - |
| 20/12/23 | Lisa Margaret McIntyre | 10,155 | - | - | - |
| 20/12/23 | Lyndal Jane York | 9,573 | - | - | - |
| 20/12/23 | Neville John Mitchell | 7,385 | - | - | - |
| 20/12/23 | Donal ODwyer | 73,418 | - | - | - |
| 30/10/23 | Lewis George Gradon | 578,556 | - | - | - |
| 13/09/22 | Miriam Cather Simpson | 1,250 | - | - | - |
| 06/07/20 | Michael Grenfell Daniel | 900,168 | - | - | - |
| 15/10/19 | Geraldine Celia McBride | 1,262 | - | - | - |
| 08/01/19 | Antony John Carter | 76,102 | - | - | - |
| 12/07/18 | Arthur Morris | 29,695 | - | - | - |
| 29/12/17 | Antony George Barclay | 150,000 | - | - | - |
| 21/12/17 | Anthony Beverley | 74,962 | - | - | - |
| 01/06/17 | Philippa Greenwood | 3,800 | - | - | - |
Analysts’ Forecasts
| profit2021 | profit2022 | eps2021 | dps2021 | sales2021 | ebit2021 | ebitda2021 | |
|---|---|---|---|---|---|---|---|
| mean | 254.7 | 43.9 | 41.0 | 1,711.6 | 351.9 | 465.5 | |
| high | 254.7 | 43.9 | 41.0 | 1,711.6 | 351.9 | 465.5 | |
| low | 254.7 | 43.9 | 41.0 | 1,711.6 | 351.9 | 465.5 | |
| sample | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Disclaimer
Data on this page is from BusinessDesk and NZX Ltd for information purposes
only. Details are believed to be accurate but no warranty is given as to
accuracy, timeliness, reliability or completeness. No person should rely on
the contents of the report and all persons should obtain independent
professional advice before acting on any information connected with or
contained in this report.
Last
Updated: 18/12/2023
Markets News
Markets
Market Close
FPH, Fletcher drive NZ stocks lower
Dips for Fisher and Paykel Healthcare and Fletcher Building drive market down.
Primary Sector
Two executives depart Bremworth
The two resignations follow chief executive Greg Smith's departure.
Property
Investore bullish on outlook for commercial property
The company’s rental income rose 1.64%.
Retail
Forsyth Barr sees future upside in Briscoe initiatives
Management gave details on the company's roadmap for growth at the AGM on Thursday.
Markets
Fletcher Building to disestablish standalone Australian division
It will switch to a trans-Tasman model.
